Sign in
4

Changes in Ownership

OptimizeRx Corp Filed Acc 0001628280-24-017549

CFO/COO acquired 7,083 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Stelmakh Edward CFO/COO 2024-02-15 Grant or award +7,083 14,765 D
Loading xslF345X05/wk-form4_1713968169.xml…